PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions
Abstract
Treatment with tyrosine kinase inhibitors (TKIs) results in remission and prolongation of survival, but fails to eliminate the leukemia stem cells (LSCs) responsible for disease development and...
Paper Details
Title
PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions
Published Date
Jun 22, 2018
Journal
Volume
60
Issue
1
Pages
262 - 264
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History